Other studies have shown that FGFR2-induced cell signaling, with AKT activation, is a driver of keratinocyte differentiation and regulates cell differentiation in ESCC [71] and the survival/maintenance of cancer stem-like cells in ESCC [69]. The gene discussed is FGFR2; the disease is cancer.